April 1, 2024 | Pre-Congress Workshops
April 2 - 4, 2024 | Main Congress Days
WALTER E CONVENTION CENTER, WASHINGTON D.C.
Attendees
Speakers
Exhibitors
Start-ups
Days
Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more
250+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions
Networking is at the heart of World Vaccine Congress Washington. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking
Dominic Andrada is a Senior Manager for Scientific Applications in the LTG Marketing Group at Luminex Corporation. His professional career spans over 20 years intersecting product development, marketing, business development, and biopharma research. His focus is developing collaborations to utilize ...
Partner, NVG LLC. Coalition manager extraordinaire, currently running the Adult Vaccine Access Coalition (AVAC) and managing the Infectious Disease Prevention Network (IDPN). Subject matter expert in vaccine policy, diabetes-related policy issues, and preventive health. Broad reach in the patient...
Dr. Crooke is the Lead Microbiologist for Vaccine Immunology in the Viral Vaccine Preventable Diseases Branch (VVPDB) at the Centers for Disease Control and Prevention. He is a member of the American Society for Virology and an investigator in the Center for Childhood Immunizations and Vaccines at...
Dr. Delese Mimi Darko holds a Doctorate Degree in Pharmacology and a Bachelor of Pharmacy from the Kwame Nkrumah University of Science and Technology (KNUST),and a master’s degree in Business Administration from the University of Northampton.With her over 32-years of experience in the field of food ...
Professor and Vice Chair of Research in the Department of Laboratory Medicine and Pathology at the University of Washington and Core Scientist in the Infectious Disease and Translational Medicine Unit of the Washington National Primate Research Center, Seattle, WA. Dr. Derdeyn uses human subjects...
As a medical oncologist, Kyle saw first hand the devastating effects that serious disease can have on patients and their families. This is why, after completing medical school, residency, and fellowship, he dedicated his life’s work to finding better therapies for those who desperately need them. ...
Wolfgang Leitner is the chief of the Innate Immunity Section of the Basic Immunology Branch/Division of Allergy, Immunology and Transplantation (DAIT), at the National Institute of Allergy and Infectious Diseases (NIAID/NIH). He oversees the NIAID Vaccine Adjuvant Program, and his section manages...
PhD in industrial organic chemistry awarded at the University of Florence, Italy, in 2006. More than 15 years experience in the field of vaccines development, focusing her research on bacterial vaccines against AMR pathogens mainly affecting impoverished communities. Involved in the development of...
Dr. Jomana Musmar serves as the Designated Federal Officer and Executive Director of the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria--a US federal advisory committee addressing all issues related to AMR through a One Health approach. Dr. Musmar also serves as a Senior...
He holds a degree in Industrial Pharmacy from Faculdade Oswaldo Cruz, a specialist in Health Law from USP and in Business Management from ESPM. He has taken complementary courses in the area of biotechnology at North Caroline State University and Massachusetts Institute of Technology. He began his...
Dr. Daniel Salmon is a Professor in Global Disease Epidemiology and Control and the Director for the Institute for Vaccine Safety at Johns Hopkins Bloomberg School of Public Health. His primary research and practice interests are in optimizing the prevention of childhood infectious diseases through ...
Graduated in Pharmacy from the University of Brasília (UnB) and in History from the State University of Londrina (UEL), Gustavo is a specialist in Public Health from the State University of Maringá (UEM), Master in Pharmacology and Toxicology from the Oswaldo Cruz Foundation (Fiocruz) and doctoral...
Emmett received his undergraduate degree in Biology from Harvard College in 1974 and a simultaneous M.A. in Biology. He received MD and PhD degrees having attended medical school and graduate school at the Duke University School of Medicine from 1975 to 1981. He completed internship, residency and...
Dr. Alessandro Sette has devoted more than 35 years of study towards understanding the immune response, measuring immune activity, and developing disease intervention strategies against cancer, autoimmunity, allergy, and infectious diseases. The laboratory is defining in chemical terms the specific ...
Dr. Smith is the Founder, President, and Principal Investigator of VRG/NOCCR, the AMR Knoxville and New Orleans locations. He is also the CEO of Alliance for Multispecialty Research, LLC (AMR) and its 26 locations across the US. Dr. Smith has been involved as a Principal Investigator for 40 years...
Dr. Newman has more than 30 years’ experience in the biotechnology sector serving in senior management roles at GeoVax (Atlanta, GA), PaxVax (San Diego, CA), Pharmexa (Horsholm, Denmark), Epimmune (San Diego, CA), Vaxcel (Atlanta, GA), Apollon (Philadelphia, PA) and Cambridge Biotech (Boston, MA)...
Remaining marketing opportunities for world class solution providers are selling fast.
Contact: marc.rhys-evans@terrapinn.com